Serum and DNA Samples
ProcedureTo collect serum and DNA samples from subjects
NCT Number: NCT00296114
To prospectively collect serum and DNA samples from subjects with pancreatic cancer, pancreatitis, liver disease, and from healthy and at-risk volunteers in order to identify novel biomarkers for early diagnosis, differential diagnosis, stage, natural history of the disease, response to treatment, and to identify novel targets for therapeutic interventions. In particular:
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
University Hospital (12 De Octubre), Madrid, Spain
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Criteria
Inclusion criteria
4.1 At the time of subject registration, CRAB will verify the institution's IRB date to ensure that the subject can be enrolled.
4.2 Potential study participants must meet the eligibility criteria found in Section 12.0 (Eligibility Checklist). Candidates will fall into one of four groups:
Eligibility Checklist:
To collect serum and DNA samples from subjects
Pancreatic Cancer Research Team
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02078700
Adenoma, Digestive System Diseases
Reggio Emilia, Italy
View Trial DetailsNCT02632448
Adnexal Diseases, Breast Cancer
Boston, Massachusetts, United States
View Trial DetailsNCT05131815
Astrocytoma, Behavior
Los Angeles, California, United States
View Trial DetailsNCT02089269
Digestive System Diseases, Digestive System Neoplasms
Freiburg im Breisgau, Baden-Wurttemberg, Germany
View Trial Details